Part 3 | Challenges and Uncertainties in Treatment Options
The management of patients with Chronic Rhinosinusitis with Nasal Polyps (or CRSwNP) has been subject to a major revolution of care, considering the improved knowledge of the underlying pathology over the past two decades, the recommendation to evaluate biomarkers with the indication of biologics, and the increased awareness of comorbidities.
For several years, biologics have been indicated and available in a growing number of countries for severe uncontrolled CRSwNP. However, surgery (or even revision surgery) remains the most widely used option in most countries around the world.
This debate aims to explore the main therapeutic options and to address the main question: How can we use biologics and surgery to achieve the best outcomes for patients with CRSwNP?
Panellists:
Prof. Wytske Fokkens
Prof. Adam Chaker
Prof. Joseph Han
Prof. Joaquim Mullol
Ms. Daisy Waeyenbergh
Ms. Natascha Siemes
--------------------------------------------------------------------------------------------------------------------------
📽 Subscribe to our YouTube Channel for our latest videos on Allergies and Airway Diseases
http://bit.ly/3eMvc3E
--------------------------------------------------------------------------------------------------------------------------
📧 Get in touch with the EUFOREA team for any questions
http://bit.ly/2OtlIQp
--------------------------------------------------------------------------------------------------------------------------
📌 EUFOREA is an international non-profit organisation aiming to implement optimal patient care for allergies and airway diseases (asthma, chronic rhinosinusitis, rhinitis) and comorbidities through education, research and advocacy. #euforea
📍Follow us on social media
Twitter: http://bit.ly/38wrrM7
LinkedIn: http://bit.ly/2OqtWsf
Instagram: http://bit.ly/3TGB5jM
Facebook: http://bit.ly/3cnNyFF